A - Human Necessities – 61 – L
Patent
A - Human Necessities
61
L
A61L 27/00 (2006.01) A61K 31/73 (1995.01)
Patent
CA 2165826
Herein described are therapeutic compositions that contain, as active ingredient, hyaluronic acid fragments that are characterized structurally by a chain length of from 5 to 16 monosaccharides, and by a GlcNAc residue at the non-reducing end. A particularly preferred fragment is the nonameric GlcNAc-[GlcUA-GlcNAc]4. The fragments are useful particularly to effect localized bone repair, such as for the treatment of bone fracture.
L'invention se rapporte à des compositions thérapeutiques dont le principe actif est constitué de fragments d'acide hyaluronique caractérisés structurellement par une longueur de chaîne comprise entre 5 et 16 monosaccharides, et par un résidu de GlcNAc se situant à leur extrémité non réductrice. On préfère notamment le fragment nonamère GlcNAc-[GlcUA-GlcNAc]4. Ces fragments sont particulièrement utiles pour effectuer une réparation osseuse localisée telle que le traitement de la fracture osseuse.
Bueschkens Donna
Lagarde Alain E.
Tressel Paul S.
Xu Zuojie
Allelix Biopharmaceuticals Inc.
Ridout & Maybee Llp
LandOfFree
Hyaluronic acid fragments and their therapeutic use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hyaluronic acid fragments and their therapeutic use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hyaluronic acid fragments and their therapeutic use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1777850